We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Smt. S. M. Shah Pharmacy College, Ahmedabad–Mahemdabad Highway, Bhumapura, Mahemdabad, Kheda-387130, Gujarat, India
Chromatographic analytical procedures are central to pharmaceutical quality control, development and stability assessment. High-performance liquid chromatography (HPLC) and high-performance thin-layer chromatography (HPTLC) are versatile platforms, but their performance is governed by multiple interacting experimental variables. Conventional one-factor-at-a-time development may therefore be inefficient for complex separations because it provides limited information about interactions between factors. Chemometric-assisted development, particularly when integrated with design of experiments (DoE), provides a structured framework for screening influential variables, modelling factor–response relationships and optimizing multiple analytical responses. This review discusses the role of chemometrics in HPLC and HPTLC method development, with emphasis on analytical target profile (ATP), risk assessment, critical method parameters, response selection, screening designs, response-surface methodology, regression modelling, analysis of variance, desirability-based multi-response optimization and confirmation experiments. Examples from published pharmaceutical analytical studies illustrate the practical application of DoE-supported optimization in both column and planar chromatography. The review also considers analytical procedure validation and the relationship of chemometric development with ICH Q14 and ICH Q2(R2). Advantages, limitations, practical challenges and future directions, including data-driven and machine-learning-assisted approaches, are discussed.
Reliable analytical measurements are essential for pharmaceutical quality assurance because analytical procedures support identity testing, assay, purity and impurity determination, stability assessment and routine quality control. HPLC is among the most broadly applied separation techniques in pharmaceutical analysis, whereas HPTLC provides a planar chromatographic platform suited to rapid analysis, fingerprinting and quantitative densitometry. The performance of either technique depends on the appropriate selection and control of method variables.
Chromatographic development commonly involves selection of the stationary phase, mobi le phase, detection conditions, elution mode, flow rate, temperature and other operating parameters. Because these variables can influence one another, sequential experimentation may fail to reveal important interactions. For example, changes in organic -solvent proportion can alter retention and selectivity, while pH can change analyte ionization and consequently influence retention and separation.
Chemometric approaches provide a structured framework in which several factors can be studied simultaneously and their effects on predefined analytical responses can be quantified.
The objective of this review is to consolidate the role of chemometric and DoE -based approaches in HPLC and HPTLC method optimization, explain their relationship with analytical quality by design(AQbD), and discuss model evaluation, validation, applications, limitations and future directions relevant to pharmaceutical quality assurance.
2. FUNDAMENTALS OF HPLC AND HPTLC
2.1 High-Performance Liquid Chromatography
HPLC separates components according to their differential interactions with a stationary phase and a mobile phase under controlled flow. In reversed -phase HPLC, a non -polar stationary phase such as C18 is commonly combined with an aqueous -organic mobile phase. Analyte physicochemical properties and chromatographic conditions influence retention, selectivity, efficiency and peak shape.
2.2 High-Performance Thin-Layer Chromatography
HPTLC is a planar chromatographic technique performed on precoated plates containing a suitable stationary phase. Samples are applied as controlled spots or bands, the plate is developed with a selected mobile phase and separated components are detected using densitometry or other suitable optical systems. Important observations include Rf, resolution, band shape and detector response. The ability to analyze multiple samples in parallel makes HPTLC useful for screening, identification, fingerprinting and quantitative analysis.
3. CHEMOMETRICS IN CHROMATOGRAPHIC METHOD DEVELOPMENT
Chemometrics is the application of mathematical, statistical and computational methods to obtain useful information from chemical measurements. In chromatographic development, chemometrics can support experimental planning, regression modelling, multivariate interpretation and optimization.
Rather than relying exclusively on trial -and-error experimentation, a planned design can generate information about main effects, interactions and, where appropriate, curvature within the experimental region.
3.1 Chemometric tool Role in analytical development
3.2 Chemometric vs. Simple Calculation
Mean, standard deviation or %RSD calculations performed after experimentation are not, by
themselves, chemometric optimization. A chemometric strategy uses structured multivariable
information to build or interrogate a model and then verifies that th e selected conditions provide the intended analytical performance.
TABLE 1. COMPARISON OF HPLC AND HPTLC IN CHEMOMETRIC METHOD DEVELOPMENT
|
Feature |
HPLC |
HPTLC |
|
Format |
Column |
Planar plate |
|
Primary migration measure |
Retention time |
Rf |
|
Typical optimization variables |
Mobile phase, pH, flow, temperature, gradient |
Solvent composition, saturation, development distance, detection |
|
Typical responses |
Resolution, retention, plates, tailing, area |
Rf, resolution, area/height, band shape |
|
Major strength |
High-resolution quantitative separation |
Parallel analysis and fingerprinting |
4. ANALYTICAL QUALITY BY DESIGN AND ANALYTICAL TARGET PROFILE
AQbD applies quality-by-design principles to analytical procedure development. The Analytical Target Profile (ATP) defines what the analytical procedure is intended to measure and the required performance characteristics. ICH Q14 provides a science - and risk -based framework for analytical procedure development and lifecycle management, while ICH Q2(R2) addresses validation of analytical procedures.
1. Define the analytical objective and ATP.
2. Identify product, analyte and method knowledge.
3. Perform risk assessment.
4. Identify potential critical method parameters.
5. Select critical analytical responses.
6. Apply DoE for screening and/or optimization.
7. Develop and evaluate the statistical model.
8. Define suitable operating conditions or an appropriate region.
9. Perform confirmation experiments.
10. Validate the finalized analytical procedure and establish an appropriate control strategy.
5. DESIGN OF EXPERIMENTS IN CHROMATOGRAPHIC DEVELOPMENT
DoE investigates multiple factors in a planned and statistically interpretable manner. The choice of design depends on the number and type of factors, development stage, experimental region and information required.
Design Main purpose Typical chromatographic application Two-level factorial Main effects and interactions Small number of factors Fractional factorial Efficient screening Several potential factors Plackett–Burman Factor screening Many factors with limited runs Central Composite Design Quadratic response modelling Optimization of selected quantitative factors Box–Behnken Design Quadratic optimization without extreme combinations Three or more quantitative factors Mixture design Optimization of component proportions Mobile-phase mixtures
TABLE 2. COMMON DOE DESIGNS AND THEIR ROLES
|
Design |
Primary use |
Typical application |
|
Full factorial |
Main effects and interactions
|
Small factor sets |
|
Fractional factorial |
Efficient screening
|
Several factors |
|
Plackett–Burman |
Factor screening
|
Many potential factors |
|
Central Composite Design |
Quadratic response modelling
|
Optimization of quantitative factors |
|
Box–Behnken Design |
Quadratic optimization
|
Three or more quantitative factors |
|
Mixture design |
Proportion optimization
|
Mobile-phase mixtures |
6. SELECTION OF FACTORS AND RESPONSES
6.1 Critical Method Parameters
Factors should be selected using prior scientific knowledge, risk assessment, published evidence, preliminary experiments and practical operating limits. The investigated levels should cover a meaningful and scientifically justified region. Overly narrow ranges can conceal important behaviour, whereas unnecessarily broad ranges may generate unsuitable chromatographic conditions.
6.2 HPLC Factors and Responses
HPLC optimization should begin with a scientifically reasonable chromatographic system. After preliminary selection of column and other conditions, selected high -risk variables can be investigated over a defined experimental region using an appropriate DoE.
7.1 Example Experimental Strategy
For illustration, organic-modifier proportion (X1), mobile -phase pH (X2) and flow rate (X3) may be selected after risk assessment. A Box–Behnken or Central Composite Design can be used to generate planned experimental runs. Resolution (Y1), retention time (Y2) and tailing factor (Y3) can then be measured. Regression models are fitted to describe the relationship between factors and responses, followed by model adequacy assessment and multi-response optimization.
7.2 Multi-Response Optimization
Chromatographic method development usually requires simultaneous control of several responses.
Maximizing resolution alone, for example, may result in an unnecessarily long analysis. A desirability-based approach can combine goals such as maximizing resolution, minimizing analysis time and maintaining peak symmetry within an acceptable range. The predicted optimum should always be subjected to confirmation experiments.
DoE-supported HPLC method development has been reported for pharmaceutical analysis. The supplied report highlights an RP-HPLC study of torsemide and eplerenone in which Central Composite Design and response -surface methodology were used for multivariate optimization. Such studies illustrate how planned experimentation can replace extensive trial-and-error adjustment with a model-based development strategy.
HPTLC method development can similarly bene fit from DoE because solvent composition, chamber saturation, development distance and detection conditions may jointly affect migration and separation.
The Rf value is particularly important because excessively low or high migration can reduce practical separation quality.
8.1 Published HPTLC Evidence
The supplied report identifies published DoE -supported HPTLC examples involving efinaconazole, retapamulin, and a stability -indicating assay involving roxithromycin and ambroxol hydrochloride.
These examples demonstrate the use of response -surface designs, optimization of chromatographic variables and subsequent method validation.
8.2 HPTLC Optimization Workflow
1. Select a suitable stationary phase and establish an initial solvent system.
2. Identify high-risk chromatographic variables.
3. Select a screening or response-surface design.
4. Perform planned HPTLC experiments.
5. Measure Rf, resolution, response and other predefined attributes.
6. Fit the model and evaluate model adequacy.
7. Select the optimum region using predefined criteria.
8. Perform confirmation experiments.
9. Validate the finalized method.
TABLE 3. TYPICAL FACTORS AND RESPONSES
|
Technique |
Factors |
Responses
|
|
HPLC |
Organic modifier, pH, flow, temperature, gradient
|
Resolution, retention time, tailing, efficiency, detector response
|
|
HPTLC |
Solvent composition, saturation, development distance, application/detection
|
Rf, resolution, densitometric response, band shape |
For quantitative factors, a second-order polynomial is frequently used for response-surface modelling when justified by the selected design. The general form is:
Y = β? + Σβ?X? + Σβ??X?X? + Σβ??X?² + ε
Linear terms represent primary effects, interaction terms represent combined factor effects, and quadratic terms describe curvature. Model interpretation should consider statistical significance, model adequacy, residual behaviour, practical significance and experimental confirmation rather than relying on coefficient magnitude alone.
9.1 Model Evaluation
9.2 Response-Surface Plots
Contour and three -dimensional response -surface plots can show how two factors jointly affect a response while another factor is held constant. Such plots are useful for visualizing regions that satisfy multiple criteria, but graphical interpretation should be supported by statistical evidence and confirmation experiments.
Optimization and validation are distinct activities. Optimization de termines suitable analytical conditions, whereas validation establishes that the finalized procedure performs adequately for its intended purpose. Depending on the analytical application, important characteristics include specificity/selectivity, accuracy, precision, linearity, range, detection limit, quantitation limit and robustness. System suitability is used to confirm system performance during analytical use.
TABLE 4. VALIDATION CHARACTERISTICS AND PURPOSE
|
Characteristic
|
Purpose |
|
Specificity/selectivity |
Demonstrate measurement of the intended analyte in the presence of relevant components |
|
Accuracy |
Assess closeness to an accepted/reference value |
|
Precision |
Assess agreement among repeated measurements |
|
Response relationship/linearity |
Demonstrate suitable relationship over the intended range |
|
Range |
Define interval over which required performance is demonstrated |
|
LOD/LOQ |
Characterize detection/quantitation capability when applicable |
|
Robustness |
Evaluate performance under deliberate small changes when appropriate |
|
System suitability |
Confirm system performance before/within analytical use |
11. RELATIONSHIP WITH ICH Q14 AND ICH Q2(R2)
ICH Q14 provides a framework for science - and risk-based analytical procedure development and supports analytical procedure lifecycle thinking. ICH Q2(R2) provides the framework for demonstrating that an analytical procedure is fit for its intended purpose. Chemometric optimization can connect these principles by translating the analytical objective into measurable r esponses, prioritizing factors through risk assessment, using DoE for structured experimentation, quantifying factor–response relationships through modelling, selecting an operating region, confirming predictions experimentally and then validating the final procedure.
TABLE 4. RELATIONSHIP TO CHEMOMETRIC OPTIMIZATIN
|
Development element |
Chemometric contribution
|
|
Analytical objective/ATP responses
|
Defines target performance and analytical |
|
Risk assessment
|
Prioritizes factors for experimental study |
|
DoE
|
Provides structured experimentation |
|
Model development
|
Quantifies factor–response relationships |
|
Optimization |
Identifies suitable operating conditions or region |
|
Confirmation |
Tests model prediction experimentally
|
|
Validation Demonstrates fitness for intended purpose |
Validation Demonstrates fitness for intended purpose |
|
Lifecycle monitoring |
Supports continued evaluation of analytical performance |
A well-developed analytical procedure reduces the risk t hat analytical variability will obscure true product quality. Chemometric development can make relationships between method parameters and analytical performance more explicit, supporting rational control of critical variables and risk -based pharmaceutical quality systems.
The major practical challenge is translating chemical and chromatographic knowledge into suitable factors and measurable responses. A statistically sophisticated design cannot compensate for inappropriate stationary-phase selection, poor sample preparation, unsuitable detection conditions or unrealistic operating ranges. Chemometrics should therefore complement, rather than replace, chromatographic expertise.
FUTURE PERSPECTIVES
Analytical development is increasingly moving from traditional one-factor-at-a-time experimentation toward structured DoE, AQbD and data -driven optimization. Future developments may integrate automated experimentation, richer chromatographic datasets, multivariate modelling and machine -learning approaches. For HPTLC, DoE -supported optimization is likely to remain useful because several solvent and development variables can jointly affect migration and separation. The priority should not simply be increasing model complexity; it should be obtaining better analytical knowledge, improving robustness, reducing unnecessary experimentation and maintaining scientific interpretability.
CONCLUSION
Chemometric-assisted optimization provides a rational framework for HPLC and HPTLC method development by combining analytical knowledge, risk assessment, DoE, statistical modelling and multi-response optimization. HPLC development may investigate mobile-phase composition, pH, flow rate, temperature, gradient conditions and column chemistry, whereas HPTLC development may investigate solvent composition, chamber saturation, development distance, application and detection conditions. Published pharmaceutical examples demonstrate that DoE -supported optimization is a practical approach. Nevertheless, the predicted optimum should be experimentally confirmed and the finalized procedure appropriately validated. Integration with ICH Q14 and ICH Q2(R2) strengthens the connection between analytical method development, risk -based decision-making and analytical lifecycle management. The most effective implementation is therefore not simply the use of statistical software, but a scientifically justified sequence linking the analytical objective, critical factors, responses, model adequacy, confirmation and validation.
16. RESULTS AND DISCUSSION
The reviewed literature demonstrates that chemometric and DoE-based approaches can be integrated into pharmaceutical chromatographic development to study multiple method variables, quantify interactions and support multi-response optimization. The principal findings are summarized in the following tables and workflow.
17. AUTHOR DECLARATION
The author declares that this manuscript is a review article prepared through substantial restructuring, expansion and critical synthesis of an M.Pharm academic report and relevant scientific literature. The manuscript has not been previously published as a journal article and is not being considered simultaneously by another journal. The author has reviewed and approved the final manuscript. Any journal-specific requirements concerning prior academic-report or thesis-derived content will be disclosed to the target journal. The author declares no conflict of interest related to this manuscript.
18. CONFLICT OF INTEREST
The author declares that there is no conflict of interest associated with this review article.
19. FUNDING
No external funding was received for the preparation of this review article.
REFERENCES
Compendial Procedures.
United States Pharmacopeia–National Formulary. General Chapter <621
Chromatography.
Validation for Drugs and Biologics: Guidance for Industry.
Final Guidance for Industry. 2024.
Final Guidance for Industry. 2024.
Step 5 – Revision 1. 2024.
Procedures. Step 5 – Revision 1. 2024.
chemistry: a review. Analytica Chimica Acta.
Chromatography B.
Analysis of recent pharmaceutical analytical methods using quality -by-design principles.
Journal of Chromatography A.
method development and validatio n using quality by design principles. Journal of
Pharmaceutical and Biomedical Analysis.
Discovery. Wiley.
Compendial Procedures.
United States Pharmacopeia–National Formulary. General Chapter <621
Chromatography.
Validation for Drugs and Biologics: Guidance for Industry.
Final Guidance for Industry. 2024.
Final Guidance for Industry. 2024.
Step 5 – Revision 1. 2024.
Procedures. Step 5 – Revision 1. 2024.
chemistry: a review. Analytica Chimica Acta.
Chromatography B.
Analysis of recent pharmaceutical analytical methods using quality -by-design principles.
Journal of Chromatography A.
method development and validatio n using quality by design principles. Journal of
Pharmaceutical and Biomedical Analysis.
Discovery. Wiley.
Hemani Chauhan, Shivani Jani, Dr. Pinak Patel, Dr. Krunal Detholia, Chemometric-Assisted Optimization of HPLC and HPTLC Methods In Pharmaceutical Quality Assurance, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 10, 1050-1061, https://doi.org/10.5281/zenodo.23210721
10.5281/zenodo.23210721